Erratum
for
Hochster et al., J Clin Oncol 26 (21) 3523-3529.
Journal of Clinical Oncology, Vol 26, No 28 (October 1), 2008: pp. 4697
© 2008 American Society of Clinical Oncology.
DOI: 10.1200/JCO.2008.19.8630
ERRATUM
The July 20, 2008, article by Hochster et al, entitled, "Safety and Efficacy of Oxaliplatin and Fluoropyrimidine Regimens With or Without Bevacizumab As First-Line Treatment of Metastatic Colorectal Cancer: Results of the TREE Study" (J Clin Oncol 26:3523-3529, 2008) contained errors.
In Tables 1, 2, 3 and 4, the following abbreviations were incorrectly given and should have been:
TREE, Three Regimens of Eloxatin Evaluation; mFOLFOX6, bolus and infusion fluorouracil and leucovorin with oxaliplatin; bFOL, bolus fluorouracil and low-dose leucovorin with oxaliplatin; CapeOx, capecitabine with oxaliplatin.
In Table 4, the last column heading for the TREE-2 cohort was given as bFOL + Bev, whereas it should have been CapeOx + Bev.
The online version has been corrected in departure from the print.

CiteULike Complore Connotea Del.icio.us Digg Facebook Reddit Technorati Twitter What's this?
|